Stifel Financial’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $2.43M | Sell |
|
|||||
|
2024
Q4 | $2.86M | Buy |
|
|||||
|
2024
Q3 | $2.43M | Sell |
|
|||||
|
2024
Q2 | $2.28M | Sell |
|
|||||
|
2024
Q1 | $2.32M | Sell |
|
|||||
|
2023
Q4 | $2.41M | Buy |
|
|||||
|
2023
Q3 | $1.74M | Sell |
|
|||||
|
2023
Q2 | $2.27M | Buy |
|
|||||
|
2023
Q1 | $1.94M | Sell |
|
|||||
|
2022
Q4 | $1.9M | Sell |
|
|||||
|
2022
Q3 | $1.68M | Buy |
|
|||||
|
2022
Q2 | $2.06M | Sell |
|
|||||
|
2022
Q1 | $2.49M | Sell |
|
|||||
|
2021
Q4 | $2.2M | Sell |
|
|||||
|
2021
Q3 | $1.6M | Buy |
|
|||||
|
2021
Q2 | $1.62M | Sell |
|
|||||
|
2021
Q1 | $1.36M | Buy |
|
|||||
|
2020
Q4 | $977K | Sell |
|
|||||
|
2020
Q3 | $827K | Sell |
|
|||||
|
2020
Q2 | $877K | Buy |
|
|||||
|
2020
Q1 | $254K | Buy |
|
|||||
|
2019
Q4 | $479K | Buy |
|
|||||
|
2019
Q3 | $101K | Sell |
|
|||||
|
2019
Q2 | $191K | Hold |
|
|||||
|
2019
Q1 | $179K | Hold |
|
|||||
|
2018
Q4 | $167K | Hold |
|
|||||
|
2018
Q3 | $319K | Hold |
|
|||||
|
2018
Q2 | $260K | Buy |
|
|||||
|
2018
Q1 | $304K | Hold |
|
|||||
|
2017
Q4 | $209K | Sell |
|
|||||
|
2017
Q3 | $235K | Buy |
|
|||||
|
2017
Q2 | $175K | Hold |
|
|||||
|
2017
Q1 | $229K | Hold |
|
|||||
|
2016
Q4 | $213K | Hold |
|
|||||
|
2016
Q3 | $215K | Sell |
|
|||||
|
2016
Q2 | $622K | Buy |
|
|||||
|
2016
Q1 | $392K | Sell |
|
|||||
|
2015
Q4 | $1.24M | Buy |
|
|||||
|
2015
Q3 | $524K | Hold |
|
|||||
|
2015
Q2 | $419K | Buy |
|
|||||
|
2015
Q1 | $294K | Hold |
|
|||||
|
2014
Q4 | $218K | Buy |
|